ShlomoMelmedMD
Endocrinology • Los Angeles, CADiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Professor and Dean
Dr. Melmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-423-2830Fax+1 310-423-2819
Education & Training
UCLA-VA Greater Los AngelesFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1980- UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1977 - 1980
University of Cape Town Faculty of MedicineClass of 1970
Certifications & Licensure
CA State Medical License 1979 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors:LA Area Castle Connolly, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Ultrasound Guided Octreotide LAR Injection in Acromegaly Start of enrollment: 2007 Jul 01
- Pituitary Tumor Surveillance: Pathogenic Correlation Start of enrollment: 1997 Jan 01
- Measurement of Pituitary Volume and Hormonal Changes in Patients With Post-traumatic Stress Disorder Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- A broader outlook is required to stage and classify pituitary neoplasms for patient care.Shlomo Melmed, Maria Fleseriu, John A H Wass, Ken K Y Ho
Brain Pathology. 2024-11-23 - Letter to the Editor From Ho and Melmed: Clinical Practice and Nomenclature of Pituitary Neoplasms: Common Sense Must Prevail.Ken K Y Ho, Shlomo Melmed
The Journal of Clinical Endocrinology and Metabolism. 2024-09-16 - GIP receptor antagonism eliminates paradoxical growth hormone secretion in some patients with acromegaly.Mette H Jensen, Lærke S Gasbjerg, Kirsa Skov-Jeppesen, Jens C B Jacobsen, Steen S Poulsen
The Journal of Clinical Endocrinology and Metabolism. 2024-08-22
Journal Articles
- A Consensus Statement on Acromegaly Therapeutic OutcomesDavid R Clemmons, Shlomo Melmed, Anne Klibanski, Nature
Lectures
- Pituitary-Tumor EndocrinopathiesENDO 2019 - New Orleans, LA - 3/25/2019
- Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1 (Repeat)ENDO 2019 - New Orleans, LA - 3/24/2019
- Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1ENDO 2019 - New Orleans, LA - 3/24/2019
Other
- Causes and clinical manifestations of acromegalyMelmed S
http://www.uptodate.com/contents/causes-and-clinical-manifestations-of-acromegaly
UpToDate, Wolters Kluwer Health - 2012-06-05 - Diagnosis of acromegalyMelmed S
http://www.uptodate.com/contents/diagnosis-of-acromegaly
UpToDate, Wolters Kluwer Health - 2012-07-26 - Treatment of acromegalyMelmed S
http://www.uptodate.com/contents/treatment-of-acromegaly
UpToDate, Wolters Kluwer Health - 2012-06-27 - Join now to see all
Authored Content
- Pituitary-Tumor EndocrinopathiesMarch 2020
Press Mentions
Urologic Oncologist Hyung Kim, MD, Named Chair of Cedars-Sinai Department of UrologyFebruary 2nd, 2023- May Research Highlights: A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-SinaiMay 26th, 2022
- COVID Risk in T1D; Lilly to Drop Some Insulin Prices; New ADA/EASD T1D GuidelineOctober 3rd, 2021
- Join now to see all
Grant Support
- GHNIDDKPresent
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
